| COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome MT Lupo-Stanghellini, E Xue, S Mastaglio, C Oltolini, P Angelillo, ... Bone Marrow Transplantation 56 (9), 2312-2315, 2021 | 7 | 2021 |
| Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB D Clerici, L Galli, R Greco, AP Lugli, F Erbella, M Ripa, C Tassan Din, ... Blood Advances 7 (9), 1621-1634, 2023 | 6 | 2023 |
| Radiomics-based machine learning model for predicting overall and progression-free survival in rare cancer: a case study for primary CNS lymphoma patients M Destito, A Marzullo, R Leone, P Zaffino, S Steffanoni, F Erbella, ... Bioengineering 10 (3), 285, 2023 | 5 | 2023 |
| Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma AJM Ferreri, P Angelillo, F Erbella, C Cattaneo, L Verga, A Lleshi, ... Blood Advances 6 (22), 5811-5820, 2022 | 3 | 2022 |
| Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a Lysa Study from the Descar-T Registry F Erbella, E Bachy, G Cartron, E Gat, F Morschhauser, B Tessoulin, ... Blood 140 (Supplement 1), 1325-1327, 2022 | 2 | 2022 |
| Deep learning-based overall survival prediction model in patients with rare cancer: a case study for primary central nervous system lymphoma Z She, A Marzullo, M Destito, MF Spadea, R Leone, N Anzalone, ... International Journal of Computer Assisted Radiology and Surgery 18 (10 …, 2023 | 1 | 2023 |
| Ibrutinib alone or in combination with R-CHOP chemoimmunotherapy in relapsed or refractory primary central nervous system lymphoma (rrPCNSL): a «real-life» study T Calimeri, F Erbella, L Orsucci, T Aloisi, A Arcari, C Botta, A Cuccaro, ... Blood 140 (Supplement 1), 6678-6680, 2022 | 1 | 2022 |
| P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19. FM Aletti, A Ruggeri, P Angelillo, S Mastaglio, F Erbella, D Palumbo, ... HemaSphere 7 (S3), e7303650, 2023 | | 2023 |
| Impact of levofloxacin prophylaxis withdrawal on pre-engraftment bloodstream infections after allogeneic stem cell transplant D Clerici, C Oltolini, L Galli, R Greco, AP Lugli, F Erbella, M Ripa, CT Din, ... BONE MARROW TRANSPLANTATION 57 (SUPPL 1), 263-264, 2022 | | 2022 |
| SAFETY AND EFFICACY OF THE" CARMEN" REGIMEN, A NEW DOSE-DENSE SHORT-TERM THERAPY, IN PATIENTS WITH AGGRESSIVE B-CELL LYMPHOMA AND MYC REARRANGEMENT. A MULTICENTER ITALIAN … P Angelillo, F Erbella, C Liberatore, C Cattaneo, L Verga, A Lleshi, ... HAEMATOLOGICA 106 (10), 138-138, 2021 | | 2021 |
| OUTCOMES OF COVID-19 IN CELLULAR THERAPY RECIPIENTS: REAL-LIFE APPLICATION OF CIBMTR RISK FACTORS A Bruno, F Lorentino, AA Assanelli, S Marktel, R Greco, F Farina, F Giglio, ... Haematologica, 121-121, 2021 | | 2021 |
| Safety and efficacy of the “carmen” regimen, a new dose-dense short-term therapy in patients with aggressive B-cell lymphoma and myc rearrangement AJM Ferreri, P Angelillo, F Erbella, C Liberatore, C Cattaneo, L Verga, ... Hematological Oncology, 258-258, 2021 | | 2021 |
| Flat Regimen as Myeloablative Conditioning with Limited Toxicities for Autologous Stem Cell Transplantation in Patients with Acute Myeloid Leukemia: Results in 30 Patients M Bernardi, C Messina, S Mastaglio, F Lorentino, F Pavesi, MG Carrabba, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 200-201, 2020 | | 2020 |
| Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem … D Clerici, C Oltolini, R Greco, F Erbella, R Nitti, M Ripa, F Giglio, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 471-472, 2020 | | 2020 |
